Pelvital is a women's health medical device company empowering women and clinicians to restore pelvic health with effective, convenient products backed by strong clinical evidence. Their first product, Flyte®, is an FDA-cleared novel in-home treatment for stress urinary incontinence and weakened pelvic floor muscles. Unlike electrical stimulation devices or Kegel trainers, Flyte delivers mechanotherapy, a foundational treatment modality that when paired with an active pelvic floor contraction stimulates tissue regeneration and the creation of neuromuscular memory. Flyte also supports women with a complimentary Ask A (Pelvic) Physical Therapist Service staffed by Doctors of Physical Therapy specializing in pelvic floor health.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
08/01/23 | $2,680,000 | Seed |
Boomerang Ventures Edward Bergmark, PhD. VisionTech Wisconsin Investment Partners | undisclosed |
04/22/24 | $2,320,000 | Seed+ |
Blue Pacific Fund Boomerang Ventures Life Science Angels Pier 70 Ventures Tech Coast Angels | undisclosed |